The U.S. Food and Drug Administration (FDA) had requested Shire Plc to conduct a study testing the a stimulant after concerns rose regarding the effectiveness of diagnosing and treating children with attention deficit hyperactivity disorder (ADHD).
from Meta Search Alerts http://ift.tt/1hSSJ0U
via IFTTT
from Meta Search Alerts http://ift.tt/1hSSJ0U
via IFTTT
No comments:
Post a Comment